Лиза Хендриксон-Джек - Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма

86. Bretherick, Karla L., Nichole Fairbrother, Luana Avila, Sara H.A. Harbord, and Wendy P. Robinson. “Fertility and aging: do reproductive-aged Canadian women know what they need to know?” Fertility and Sterility 93, no. 7 (2010): 2162–2168.

87. Hendrickson-Jack, Lisa. “FFP 109 | The Reality of Aging & Fertility | IVF & Assisted Reproductive Technology | The Future of Fertility Treatments | Dr. Marjorie Dixon.” Fertility Friday Podcast. Podcast Audio, November 25, 2016. fertilityfriday.com/109

88. Allen, N.C., C.M. Herbert, W.S. Maxson, B. Jane Rogers, Michael Peter Diamond, and A. Colston Wentz. “Intrauterine insemination: a critical review.” Fertility and Sterility 44, no. 5 (1985): 569–580.

89. Там же; Kumar, Naina, and Amit Kant Singh. “Trends of male factor infertility, an important cause of infertility: A review of literature.” Journal of Human Reproductive Sciences 8, no. 4 (2015): 191–196.

90. Schorsch, M., R. Gomez, T. Hahn, J. Hoelscher-Obermaier, R. Seufert, and C. Skala. “Success rate of inseminations dependent on maternal age? An analysis of 4246 insemination cycles.” Geburtshilfe und Frauenheilkunde 73, no. 8 (2013): 808–811.

91. Там же.

92. Al-Fozan, Haya, Maha Al-Khadouri, Seang Lin Tan, and Togas Tulandi. “A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation.” Fertility and Sterility 82, no. 6 (2004): 1561–1563; Mitwally, Mohamed F.M., and Robert F. Casper. “Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate.” Fertility and Sterility 75, no. 2 (2001): 305–309.

93. Fouda, Usama M., and Ahmed M. Sayed. “Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial.” Reproductive Biology and Endocrinology 9, no. 1 (2011): 84.

94. Hilgers, T.W., K.D. Daly, A.M. Prebil, and S.K. Hilgers. “Cumulative pregnancy rates in patients with apparently normal fertility and fertility-focused intercourse.” The Journal of Reproductive Medicine 37, no. 10 (1992): 864–866.

95. Stanford, Joseph B., George L. White Jr., and Harry Hatasaka. “Timing intercourse to achieve pregnancy: current evidence.” Obstetrics & Gynecology 100, no. 6 (2002): 1333–1341; Gnoth, C, D. Godehardt, E. Godehardt, P. Frank– Herrmann, and G. Freundl. “Time to pregnancy: results of the German prospective study and impact on the management of infertility.” Human Reproduction 18, no. 9 (2003): 1959–1966.

96. Whitelaw, W. James. “The cervical cap self-applied in the treatment of severe oligospermia.” Fertility and Sterility 31, no. 1 (1979): 86–87.

97. Flierman, Paul A., Hendrikus V. Hogerzeil, and Douwe J. Hemrika. “A prospective, randomized, cross-over comparison of two methods of artificial insemination by donor on the incidence of conception: intracervical insemination by straw versus cervical cap.” Human Reproduction 12, no. 9 (1997): 1945–1948; Nachtigall, Robert D., Nacia. Faure, and Robert H. Glass. “Artificial insemination of husband’s sperm.” Fertility and Sterility 32, no. 2 (1982): 404–410; Coulson, C., E.A. McLaughlin, S. Harris, W.C.L. Ford, and M.G.R. Hull. “Randomized controlled trial of cervical cap with intracervical reservoir versus standard intracervical injection to inseminate cryopreserved donor semen.” Human Reproduction 11, no. 1 (1996): 84–87.

98. Diamond, Michael P., Cathy Christianson, James F. Daniell, and Anne Colston Wentz. “Pregnancy following use of the cervical cup for home artificial insemination utilizing homologous semen.” Fertility and Sterility 39, no. 4 (1983): 480–484.

99. Corson, S.L., F.R. Batzer, C. Otis, and D. Fee. “The cervical cap for home artificial insemination.” The Journal of Reproductive Medicine 31, no. 5 (1986): 349–352.

100. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2015 Assisted Reproductive Technology National Summary Report. Atlanta (GA): US Dept of Health and Human Services; 2017.

101. Там же.

102. Klipstein, Sigal, Meredith Regan, David A. Ryley, Marlene B. Goldman, Michael M. Alper, and Richard H. Reindollar. “One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.” Fertility and Sterility 84, no. 2 (2005): 435–445.

103. Cohen, Matthew A., Steven R. Lindheim, and Mark V. Sauer. “Donor age is paramount to success in oocyte donation.” Human Reproduction 14, no. 11 (1999): 2755–2758.

104. Kim, Chung-Hoon, and Gyun-Ho Jeon. “Fertility preservation in female cancer patients.” ISRN Obstetrics and Gynecology (2012): 1–6.

105. Hendrickson-Jack, Lisa. “FFP 225 | Egg Freezing and Cryopreservation | Fertility Preservation | Valerie Landis.” Fertility Friday Podcast. Podcast Audio, October 12, 2018. fertilityfriday.com/225.

106. Pierce, Nicole, and Edgar Mocanu. “Female age and assisted reproductive technology.” Global Reproductive Health 3, no. 2 (2018): e9.

1 Hendrickson-Jack, Lisa. “FFP 104 | Birth Control Pills From Your Doctor’s Perspective | Why Your Physician Isn’t Looking at the Root Cause | Alternative Medicine for Women | Dr. Miranda Naylor.” Fertility Friday Podcast. Podcast Audio, November 4, 2016. fertilityfriday.com/104.

2. Hendrickson-Jack, Lisa. “FFP 194 | How Effective Are Fertility Awareness-Based Methods… Really? | Dr. Marguerite Duane, MD.” Fertility Friday Podcast. Podcast Audio, April 13, 2018. fertilityfriday.com/194.

3. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2018 update). Baltimore and Geneva: CCP and WHO, 2018: 325–326.

4. Sussman, Steve, Thomas W. Valente, Louise A. Rohrbach, Silvana Skara, and Mary Ann Pentz. “Translation in the health professions: converting science into action.” Evaluation & the Health Professions 29, no. 1 (2006): 7–32.

1. Malpuech-Brugère, Corinne, Wojciech Nowacki, Maryvonne Daveau, Elyett Gueux, Christine Linard, Edmond Rock, Jean-Pierre Lebreton, Andrzej Mazur, and Yves Rayssiguier. “Inflammatory response following acute magnesium deficiency in the rat.” Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease 1501, no. 2 (2000): 91–98; Volpe, Stella Lucia. “Magnesium in disease prevention and overall health.” Advances in Nutrition: An International Review Journal 4, no. 3 (2013): 378S–383S; Alaimo, Katherine, Margaret A. McDowell, R.R. Briefel, A.M. Bischof, C.R. Caughman, C.M. Loria, and C.L. Johnson. “Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: third national health and nutrition examination survey, phase 1, 1988–91.” Advance Data 258 (1994): 1–28; Marier, J.R. “Magnesium content of the food supply in the modern-day world.” Magnesium 5, no. 1 (1985): 1–8.

2. Walker, Ann F., Georgios Marakis, Samantha Christie, and Martyn Byng. “Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study.” Magnesium Research 16, no. 3 (2003): 183–191; Murray, Michael T., and Joseph E. Pizzorno. (2012). The Encyclopedia of Natural Medicine, 3rd edition. London: Simon & Schuster, 896–897.

3. Chandrasekaran, Navin Chandrakanth, Christopher Weir, Sumaya Alfraji, Jeff Grice, Michael S. Roberts, and Ross T. Barnard. “Effects of magnesium deficiency – more than skin deep.” Experimental Biology and Medicine 239, no. 10 (2014): 1280–1291.